Widefield Imaging Systems Market is expected register a CAGR of around 8.6% over the forecast period (2021-2031)

Significant rise in cases of diabetic retinopathy is expected to propel the growth of the global widefield imaging systems market during the forecast period.  Widefield retinal imaging includes imaging of peripheral retina that is the main site of various ocular diseases.

Widefield imaging aids in diagnosis of peripheral retina diseases. Occurrence of eye diseases like vision impairment is rising among teenagers. Increasing usage of mobile phones and computers results into digital eye strain, and is mainly responsible for visual impairment among teenagers.

As per the Centers for Disease Control and Prevention, in 2020, approximately 6.8% of children below 18 years have been detected with vision and eye condition in the United States.

Increasing technological awareness and high focus on healthcare innovations are some of the factors encouraging the adoption of these instruments. Additionally, certain companies, as a part of their product strategies, are launching technologically advanced equipment, to consolidate larger market share.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1732

Government funding towards expansion of healthcare infrastructure will support growth in developing countries. Moreover, corporate contracts based on rent-to-own model is a feasible option in emerging economies such as India and Brazil which could create significant opportunities for manufacturers of widefield imaging systems to capitalize on.

Key Takeaways From Widefield Imaging Systems Market Study

• Widefield imaging instruments will account for 80% sales in the global market in 2021 of.
• Diabetic retinopathy is the most rapidly growing segment by indication, accounting for nearly 1/3rd of the market share.
• Standalone type of modality will remain highly preferred, contributing 56.4% towards overall sales in the market in 2021.
• Demand in hospitals accounted for 40.2% of widefield imaging systems sales in 2020.
• North America will remain the dominant widefield imaging systems market globally, exhibiting a CAGR of nearly 8.6% between 2021 and 2031.

Who Is Winning?

The key market players covered by FMI include Heidelberg Engineering GmbH, Visunex Medical Systems, Inc., Carl Zeiss Meditec AG, Clarity Medical Systems, Inc. Optos plc, and Centervue SpA.

The leading manufacturers of widefield imaging systems are focusing on new product development and launch of advanced versions of existing devices. Their aim is primarily to expand their portfolio to gain competitive edge. For instance:

• In March 2020, Heidelberg Engineering announced the reintroduction of its HRT3 Rostock Cornea Module (RCM) to offer in vivo corneal confocal microscopy in its anterior segment product portfolio, supporting cornea specialists worldwide to further improve patient care.

•  In August 2020, ZEISS announces new software for the IOLMaster® 700, with enhanced features and connectivity designed to improve the cataract surgeons’ workflow efficiency and support better outcomes for surgeons and patients.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1732

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global widefield imaging systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on widefield imaging systems segment based on component (instrument and software {image viewing software and data analysis and interpretation software}), indication (diabetic retinopathy, retinopathy of prematurity, pediatric retinal diseases, retinal vein occlusion, ocular oncology, uveitis, chorioretinal disease, glaucoma and others), modality (standalone and portable)  and end user (specialty clinics, hospitals and ambulatory surgical centers) across seven major regions.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-1732

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com